⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race
globenewswire.com
MDBH
LLY
NVO
PFE
AZN
GILD
GPCR
insitro Appoints Joe Hand as Chief People Officer to Advance Talent Strategy for Next Stage of Development
businesswire.com
AMGN
LLY
GILD
OTF + Lilly Collaboration Update on Registration Response | OMA QI Scaling Initiative Gains National Response, Bringing Together Diverse Practice Types Across 39 States Ready to Announce with Confidence?
newsfilecorp.com
LLY
Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics
globenewswire.com
LLY
Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet
prnewswire.com
LLY
Tinnitus Treatment Landscape Set for Significant Market Upswing During Forecast Period (2026-2036) as Need for Effective Therapies Intensifies | DelveInsight
prnewswire.com
SPRC
REGN
LLY
New Study Shows Scripps Patients Maintained Weight Loss After Reducing GLP-1 Treatment Frequency
globenewswire.com
LLY
NVO
SPARK NS Selects Nine Projects to Receive in Total Up to $18 Million in Funding to Advance Academic Discoveries in Autism and Parkinson’s Disease from the Lab to the Clinic
globenewswire.com
NVS
MRK
BMY
LLY
ABBV
JNJ
AZN
GILD
BIIB
REGN
AMGN
VRTX
EXPLORING THE FUTURE OF CONNECTIVITY, AI, AND DISRUPTION WITH T-MOBILE CEO SRINI GOPALAN
prnewswire.com
TROW
TMUS
GE
NYT
ISRG
NVDA
XOM
BX
LLY
Biocomputing Market Research Report 2026: Transitioning from Experimental Research to Early Enterprise Deployment Across Healthcare and Industrial Biology
globenewswire.com
LLY
AMGN